Insider · CIK 0001443705

Harford Simon N.R.

Reports to the SEC for 4 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001443705

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-27	AMICUS THERAPEUTICS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−144K sh	$14.50	−$2.08M	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−189K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−99.1K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−151K sh	—	—	0
2025-12-26	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−71.3K sh	$14.25	−$1.02M	143,595
2025-08-21	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−12.5K sh	$7.60	−$95.2K	214,898
2025-01-03	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+83.1K sh	—	—	227,427
2025-01-03	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+151K sh	—	—	150,517
2025-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−7,482 sh	$9.31	−$69.7K	144,354
2024-08-21	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−12.5K sh	$12.09	−$151K	151,836
2024-01-02	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+57.4K sh	—	—	164,365
2024-01-02	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+99.1K sh	—	—	99,073
2023-08-21	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+107K sh	—	—	106,973
2023-08-21	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+189K sh	—	—	189,043
2023-03-02	ALBIREO PHARMA, INC.U Disposition from Tender	CFO and Treasurer	UDisposition from Tender	−13.7K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−23.7K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−31.5K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−31.5K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−37.5K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Restricted Stock UnitsD Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−74K sh	—	—	0
2023-01-23	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−102 sh	$43.80	−$4,467.6	32,689
2023-01-19	ALBIREO PHARMA, INC.A Award	CFO and Treasurer	AAward	+55K sh	—	—	87,689
2023-01-19	ALBIREO PHARMA, INC.A Award	CFO and Treasurer	AAward	+55K sh	—	—	87,689
2023-01-19	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−1,776 sh	$43.80	−$77.8K	32,791
2022-10-24	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−104 sh	$19.58	−$2,035.946	33,295
2022-10-11	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−80 sh	$23.79	−$1,902.864	33,399
2022-07-22	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−106 sh	$24.67	−$2,615.158	33,479
2022-07-12	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−95 sh	$24.03	−$2,282.622	33,585
2022-04-22	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−103 sh	$32.92	−$3,391.244	33,680
2022-04-11	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−96 sh	$35.74	−$3,431.414	33,783
2022-01-24	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−416 sh	$24.88	−$10.4K	33,879
2022-01-18	ALBIREO PHARMA, INC.A Award	CFO and Treasurer	AAward	+21.6K sh	—	—	34,295
2022-01-11	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−111 sh	$25.95	−$2,880.05	12,695
2021-10-11	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−93 sh	$30.23	−$2,811.753	12,614
2021-07-13	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−98 sh	$35.02	−$3,431.96	12,707
2021-04-12	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−92 sh	$32.12	−$2,954.985	12,196
2021-01-21	ALBIREO PHARMA, INC.A Award	CFO and Treasurer	AAward	+5,500 sh	—	—	10,114
2021-01-21	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	CFO and Treasurer	AAward	+23.7K sh	—	—	23,700
2021-01-11	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−110 sh	$37.33	−$4,106.542	4,614
2021-01-11	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−110 sh	$37.33	−$4,106.542	4,614
2020-10-12	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−90 sh	$37.30	−$3,357	4,616
2020-07-10	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−92 sh	$25.56	−$2,351.52	4,706
2020-04-13	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−97 sh	$16.52	−$1,602.44	4,798
2020-01-21	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	CFO and Treasurer	AAward	+31.5K sh	—	—	31,500
2020-01-10	ALBIREO PHARMA, INC.S Sale	CFO and Treasurer	SSale	−105 sh	$27.20	−$2,856	4,895
2019-01-22	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	CFO and Treasurer	AAward	+31.5K sh	—	—	31,500
2018-10-10	ALBIREO PHARMA, INC.A Award	CFO and Treasurer	AAward	+5,000 sh	—	—	5,000
2018-10-10	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	CFO and Treasurer	AAward	+37.5K sh	—	—	37,500
2017-09-29	PAREXEL INTERNATIONAL CORPD Disposition to Issuer	See Remarks	DDisposition to Issuer	−10.7K sh	—	—	0
2017-09-29	PAREXEL INTERNATIONAL CORPStock Options (Right to Buy)U Disposition from Tender	See Remarks	UDisposition from Tender	−44K sh	$14.13	−$622K	0

Recent filings

Accepted (ET)
Apr 274
Harford Simon N.R.0001193125-26-182244
SEC(opens sec.gov)
Dec 304
Harford Simon N.R.0001193125-25-337337
SEC(opens sec.gov)
Aug 254
Harford Simon N.R.0001443705-25-000004
SEC(opens sec.gov)
Jan 64
Harford Simon N.R.0000950170-25-002421
SEC(opens sec.gov)
Aug 234
Harford Simon N.R.0000950170-24-100253
SEC(opens sec.gov)
Jan 44
Harford Simon N.R.0000950170-24-002094
SEC(opens sec.gov)
Aug 234
Harford Simon N.R.0001209191-23-047104
SEC(opens sec.gov)
Mar 24
Harford Simon N.R.0001209191-23-014786
SEC(opens sec.gov)

Companies

Address

47 HULFISH STREET

PRINCETON, NJ, 08542